Insights. A Journal of Hope.

Explore the stories, research, and real-world results shaping the future of medication adherence and security. From case studies and human-interest features to expert commentary and emerging technology, iPill™ Insights highlights how innovation and compassion come together to make medication safer for everyone.

iPill™ Insights

From Our Team.

Third-Party Insights

From the web.

iPill™ Insights. From Our Team.

When MOUD Medication Adherence Is Intelligent Harm Reduction

Taking MOUD medication as prescribed is a smart way to reduce harm. It lowers the risk of overdose, helps prevent relapses, and keeps people connected to care. In opioid use disorder treatment, sticking to prescribed medication is not a weakness or a sign that someone isn’t in recovery. Instead, it often makes recovery safer, more stable, and more sustainable. Why Adherence Matters Medications...

Overdose Risk After Prison Release: What Families Must Know in the First 30 Days

When someone you love is released from jail or prison, it can feel like a long-awaited turning point. You’ve likely carried worry for months or even years, hoping for the day they would come home. It’s natural to want this moment to mean a fresh start, something stable, something hopeful, something different. What most families are not told, however, is that the first few weeks after release can...

High-Risk Populations in the Opioid Crisis: Who Is Being Left Behind

Who’s Being Left Behind in the Opioid Crisis? The opioid epidemic continues to touch millions of lives across America—but not everyone faces the same challenges. Some people don’t just fall through the cracks; the system practically pushes them through. For those on the margin-returning citizens, people in recovery housing, individuals in rural communities, the system was not built for them....

The MOUD Adherence Crisis: Why Patients Drop Out of Treatment

Medication for Opioid Use Disorder (MOUD) works. It saves lives, reduces overdose risk, and gives people a real chance to stabilize. But if we’re honest, there’s a gap between what works in theory and what actually happens in people’s lives. The challenge isn’t starting treatment—it’s staying in it long enough for it to matter. Many patients begin MOUD with hope. They show up, they try, they...

MOUD Works. Adherence Fails. Why Recovery Depends on What Happens Next.

The medications work. The question is whether people can take them. “The medication supports recovery. The logistics undermine it.” In 2022, an estimated 6.1 million Americans aged 12 or older were living with an opioid use disorder. That number isn’t just a data point from a federal survey. It represents mothers, sons, coworkers, neighbors, and friends whose lives have been reshaped by...

How the iPill™ Dispenser Can Close a Major Gap in SUD & MH IOP Treatment

Access to medication is one of the biggest challenges for people in substance-use and mental-health treatment. Even when clients want to stay compliant, life can make it difficult—limited transportation, long work hours, unstable housing, or strict re-entry requirements often get in the way. A new option is emerging that could change that: the iPill™ dispenser. The iPill™ is a secure,...

Third-Party Insights. Worth Your Time.

Articles

📝 The Morphine Maintenance Movement [RR Blog] Read↗
📝 Empower Patients to Use OTC Naloxone Safely [pharmacytimes.com] Read↗

Videos

🎥The History of Opioid Addiction [TED] Watch↗

Podcasts

🎙️America’s Opioid Epidemic [NPR] Listen↗